IDVSmall business
BPA (single-award IDV) 36E79720A0008UNITED THERAPEUTICS CORP
Overview
Award facts
- Obligated on orders under this IDV
- $783.05K
- $783,055 across 6 orders
- Period of performance
- From Apr 24, 2020
- Modifications
- 15
- Latest action Dec 4, 2024
- Contract type
- BPA (single-award IDV)
- PIID 36E79720A0008
Description of requirement
BPA FOR ORENTIRAM, REMODULIN, TYVASO, AND UNITUXIN
Dates and value
- Award date
- Signed on Apr 24, 2020
- Ordering period ends
- Apr 23, 2025
- Ceiling
- Ceiling (single-award vehicle): $50,000,000
- Parent contract vehicle
- 36F79720D0104 (FSS, multiple award)
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Dec 4, 2024. View on USAspending · Recipient on SAM.gov
Recipient
LocationSILVER SPRING, MD
UEIKK5FBFA43JS7
CAGE code3P7X8
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyUNITED THERAPEUTICS CORP
Business types and certifications
For-profit organizationCorporation (not tax-exempt)Manufacturer of goods
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Veterans Affairs
- NAC PHARMACEUTICALS (36E797)
- Funded by
- Department of Veterans Affairs
- NAC PHARMACEUTICALS (36E797)
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- Not reported
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- VA-797P-12-Q-0002(as reported)
Contract details
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
Transaction history
Modification history
- Base award
- Apr 24, 2020
- Latest action
- Dec 4, 2024 — Supplemental agreement (within scope)Modification P00015
- Latest substantive action
- Dec 4, 2024 — Supplemental agreement (within scope)Modification P00015
- Actions by type
- Base award1
- Supplemental agreement (within scope)11
- Option exercised4
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Socio-economic and policy
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
Structure
- Award or IDV
- IDV
- IDV type
- BPAE
- Multiple or single award
- Single awardS
- Parent vehicle type
- FSSC
- Parent vehicle: multiple or single award
- Multiple awardM
- Parent vehicle agency
- Department of Veterans Affairs3600
- Awarding agency code
- 3600
- Awarding sub-tier code
- 3600
- Contracting office code
- 36E797
- Transactions recorded under this award key
- 16
Funding
- Funding agency code
- 3600
- Funding sub-tier code
- 3600
- Funding office code
- 36E797